Nevro Spine-Stim Patents Escape Re-Review By PTO
This article was originally published in The Gray Sheet
Executive Summary
The Patent Trial and Appeals Board won’t review a Nevro spinal cord stimulator patent after a challenge from Boston Scientific claimed the patent was invalid because it was too similar to prior knowledge in the field. The unusual decision not to even launch a so-called inter partes review in this case should be comforting to device patent holders, an attorney says.